| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $17.9M | -1.9% |
| Cost of Revenue | $8.4M | -8.5% |
| Gross Profit | $9.5M | +4.8% |
| R&D Expense | $3.9M | -22.9% |
| SG&A Expense | $8.8M | -17.8% |
| Operating Income | -$10.5M | +30.8% |
| Pre-tax Income | -$11.3M | +25.5% |
| Net Income | -$11.3M | +25.5% |
| EPS (Basic) | -$0.56 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.5M | -24.8% |
| Accounts Receivable | $7.2M | +28.2% |
| Inventory | $4.6M | -9.5% |
| Current Assets | $18.8M | -6.8% |
| Total Assets | $26.7M | -7.8% |
| Current Liabilities | $7.5M | -7.1% |
| Total Liabilities | $13.9M | -14.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.8M | +18.3% |
| Capital Expenditures | $37K | -76.4% |
| Investing Cash Flow | -$37K | +76.4% |
| Financing Cash Flow | $7.8M | +2132.5% |
| Free Cash Flow | -$9.9M | +19.1% |
| +49.1% |
| Stockholders' Equity |
| $12.7M |
| +0.8% |